Why is CorMedix stock crashing today: is it worth buying on the dip?

Investors are bailing on CorMedix (NASDAQ: CRMD) today after the biotech firm guided for up to $320 million in revenue for its fiscal 2026. The announcement isn't sitting well with shareholders, prima... ...